Logo image of SEQUA.BR

SEQUANA MEDICAL NV (SEQUA.BR) Stock Fundamental Analysis

EBR:SEQUA - Euronext Brussels - BE0974340722 - Common Stock - Currency: EUR

1.525  +0.03 (+2.35%)

Fundamental Rating

1

SEQUA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. SEQUA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SEQUA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SEQUA had negative earnings in the past year.
SEQUA had a negative operating cash flow in the past year.
In the past 5 years SEQUA always reported negative net income.
In the past 5 years SEQUA always reported negative operating cash flow.
SEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFSEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

The Return On Assets of SEQUA (-251.92%) is worse than 90.91% of its industry peers.
Industry RankSector Rank
ROA -251.92%
ROE N/A
ROIC N/A
ROA(3y)-200.39%
ROA(5y)-179.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEQUA.BR Yearly ROA, ROE, ROICSEQUA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SEQUA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEQUA.BR Yearly Profit, Operating, Gross MarginsSEQUA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
SEQUA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SEQUA has been increased compared to 5 years ago.
SEQUA has a worse debt/assets ratio than last year.
SEQUA.BR Yearly Shares OutstandingSEQUA.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
SEQUA.BR Yearly Total Debt VS Total AssetsSEQUA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

SEQUA has an Altman-Z score of -35.22. This is a bad value and indicates that SEQUA is not financially healthy and even has some risk of bankruptcy.
SEQUA has a worse Altman-Z score (-35.22) than 85.45% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -35.22
ROIC/WACCN/A
WACC7.06%
SEQUA.BR Yearly LT Debt VS Equity VS FCFSEQUA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 0.41 indicates that SEQUA may have some problems paying its short term obligations.
SEQUA has a Current ratio of 0.41. This is amonst the worse of the industry: SEQUA underperforms 89.09% of its industry peers.
A Quick Ratio of 0.29 indicates that SEQUA may have some problems paying its short term obligations.
SEQUA has a Quick ratio of 0.29. This is amonst the worse of the industry: SEQUA underperforms 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.29
SEQUA.BR Yearly Current Assets VS Current LiabilitesSEQUA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

SEQUA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.72%, which is quite impressive.
SEQUA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.54%.
The Revenue has been decreasing by -7.10% on average over the past years.
EPS 1Y (TTM)24.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.16%
Revenue 1Y (TTM)-48.54%
Revenue growth 3Y-9.58%
Revenue growth 5Y-7.1%
Sales Q2Q%-72.54%

3.2 Future

The Earnings Per Share is expected to grow by 19.24% on average over the next years. This is quite good.
Based on estimates for the next years, SEQUA will show a very strong growth in Revenue. The Revenue will grow by 150.02% on average per year.
EPS Next Y56.12%
EPS Next 2Y31.47%
EPS Next 3Y19.24%
EPS Next 5YN/A
Revenue Next Year-88.93%
Revenue Next 2Y245.01%
Revenue Next 3Y150.02%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SEQUA.BR Yearly Revenue VS EstimatesSEQUA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
SEQUA.BR Yearly EPS VS EstimatesSEQUA.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SEQUA. In the last year negative earnings were reported.
Also next year SEQUA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEQUA.BR Price Earnings VS Forward Price EarningsSEQUA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEQUA.BR Per share dataSEQUA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

SEQUA's earnings are expected to grow with 19.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.47%
EPS Next 3Y19.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SEQUA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANA MEDICAL NV

EBR:SEQUA (3/7/2025, 7:00:00 PM)

1.525

+0.03 (+2.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)04-03 2025-04-03/amc
Inst Owners49.55%
Inst Owner ChangeN/A
Ins Owners3.45%
Ins Owner ChangeN/A
Market Cap79.94M
Analysts83.64
Price Target4.39 (187.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.28%
PT rev (3m)18.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)35.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-33.33%
Revenue NY rev (3m)-61.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 184.41
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.01
BVpS-0.37
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -251.92%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-200.39%
ROA(5y)-179.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100.03%
Cap/Sales 151.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.29
Altman-Z -35.22
F-Score2
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)134.83%
Cap/Depr(5y)117.19%
Cap/Sales(3y)87.03%
Cap/Sales(5y)61.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.16%
EPS Next Y56.12%
EPS Next 2Y31.47%
EPS Next 3Y19.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-48.54%
Revenue growth 3Y-9.58%
Revenue growth 5Y-7.1%
Sales Q2Q%-72.54%
Revenue Next Year-88.93%
Revenue Next 2Y245.01%
Revenue Next 3Y150.02%
Revenue Next 5YN/A
EBIT growth 1Y23.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.85%
EBIT Next 3Y14.39%
EBIT Next 5YN/A
FCF growth 1Y1.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.39%
OCF growth 3YN/A
OCF growth 5YN/A